LEGN logo

Legend Biotech Corporation (LEGN)

Profile

Full Name

Legend Biotech Corporation

Ticker

NASDAQ: LEGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 5, 2020

Indexes

Not included

Website

https://www.legendbiotech.com

Employees

2700

Key Details

Price

$34.62(-4.05%)

Market cap

$6.39B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$627.24M(+119.97% YoY)

Annual EPS

-$0.96(+67.35% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $34.62
    LEGN price is $34.62

    30-Day Relative Volume

    0.91
    LEGN 30-day relative volume is 0.91

    Price Performance

    Price Most recent change

    -4.05%
    LEGN price was down -4.05% on Sep 8, 2025

    Price YTD change

    +6.39%
    LEGN price is up +6.39% since January 1st

    Price 1-year change

    -28.31%
    LEGN price is down -28.31% year-on-year

    Price 3-year change

    -20.63%
    LEGN price is down -20.63% over the past 3 years

    Price Range

    Price All-time high

    $77.32
    LEGN price is currently -55.23% below its historical high of $77.32

    Price 3-year low

    $27.34
    LEGN price is currently +26.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.39B
    LEGN market capitalization is $6.39 billion

    Market cap 3-year change

    -10.73%
    LEGN market capitalization is down -10.73% over the past 3 years

    Market cap All-time high

    $13.87B
    LEGN market capitalization is currently -53.94% below its historical high of $13.87 billion

    Market cap sector rank

    89.34%
    LEGN market capitalization is higher than 89.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.76%
    LEGN shares outstanding is up +0.76% year-on-year

    Shares Outstanding 3-Year Change

    +12.48%
    LEGN shares outstanding is up +12.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.47
    LEGN beta is 0.47

    200-day SMA

    $35.59
    LEGN price is currently -2.73% below its 200-day simple moving average

    50-day SMA

    $37.90
    LEGN price is currently -8.66% below its 50-day simple moving average

    RSI

    41.42
    LEGN 14-day relative strength index is 41.42

    Volume

    0.91
    LEGN 30-day relative volume is 0.91

    ATR

    $1.36
    LEGN average true range is $1.36

    10-day Historical Volatility

    45.18%
    LEGN 10-day historical volatility is 45.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $627.24M
    LEGN annual revenue is $627.24 million

    Revenue Analysts estimate

    $1.05B
    LEGN annual revenue is currently -40.44% lower than the consensus analysts' forecast

    Revenue 1-year change

    +119.97%
    LEGN annual revenue is up +119.97% year-on-year

    Revenue Sector rank

    82.53%
    LEGN annual revenue is higher than 82.53% of companies in Healthcare sector

    EPS

    EPS

    -$0.96
    LEGN annual earnings per share is -$0.96

    EPS Analysts estimate

    -$0.68
    LEGN annual earnings per share is currently +41.72% higher than the consensus analysts' forecast

    EPS 1-year change

    +67.35%
    LEGN annual earnings per share is up +67.35% year-on-year

    EPS Sector rank

    52.69%
    LEGN annual earnings per share is higher than 52.69% of companies in Healthcare sector

    Profit

    Gross profit

    $369.30M
    LEGN annual gross profit is $369.30 million

    Gross margin

    58.88%
    LEGN annual gross profit margin is 58.88%

    Operating profit

    -$309.57M
    LEGN annual operating income is -$309.57 million

    Operating margin

    -49.35%
    LEGN annual operating profit margin is -49.35%

    Net income

    -$177.03M
    LEGN annual net profit is -$177.03 million

    Net margin

    -28.22%
    LEGN annual net profit margin is -28.22%

    Expenses

    Total expenses

    $804.27M
    LEGN annual total expenses is $804.27 million

    Operating expenses

    $678.87M
    LEGN annual total operating expenses is $678.87 million

    Cost of goods sold

    $257.94M
    LEGN annual cost of goods sold is $257.94 million

    Selling, general & administrative expenses

    $0.00
    LEGN annual SGA is $0.00

    Depreciation and amortization

    $23.36M
    LEGN annual depreciation & amortization is $23.36 million

    Interest expense

    $0.00
    LEGN annual interest expense is $0.00

    Income tax

    $18.89M
    LEGN annual income tax is $18.89 million

    EBIT & EBITDA

    EBIT

    -$309.57M
    LEGN annual earnings before interest & taxes is -$309.57 million

    EBITDA

    -$286.21M
    LEGN annual EBITDA is -$286.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.67B
    LEGN annual total assets is $1.67 billion

    Non current assets

    $386.24M
    LEGN annual long term assets is $386.24 million

    Current assets

    $1.28B
    LEGN annual total current assets is $1.28 billion

    Cash and cash equivalents

    $1.12B
    LEGN annual cash & cash equivalents is $1.12 billion

    Accounts receivable

    $6.29M
    LEGN annual accounts receivable is $6.29 million

    Inventory

    $23.90M
    LEGN annual inventory is $23.90 million

    Liabilities

    Total liabilities

    $623.45M
    LEGN annual total liabilities is $623.45 million

    Long term liabilities

    $345.81M
    LEGN annual total long term liabilities is $345.81 million

    Current liabilities

    $277.64M
    LEGN annual total current liabilities is $277.64 million

    Accounts payable

    $38.59M
    LEGN annual accounts payable is $38.59 million

    Debt

    Total debt

    $350.60M
    LEGN annual total debt is $350.60 million

    Total debt 1-year change

    +6.67%
    LEGN annual total debt is up +6.67% year-on-year

    Long term debt

    $345.81M
    LEGN annual long term debt is $345.81 million

    Short term debt

    $4.79M
    LEGN annual short term debt is $4.79 million

    Equity & Capital

    Shareholders equity

    $1.04B
    LEGN annual stockholders equity is $1.04 billion

    Book value

    $1.04B
    LEGN annual book value is $1.04 billion

    Retained earnings

    -$1.66B
    LEGN annual retained earnings is -$1.66 billion

    Working capital

    $1.01B
    LEGN annual working capital is $1.01 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$141.35M
    LEGN annual cash flow from operations is -$141.35 million

    Cash from operations 1-year change

    +63.23%
    LEGN annual cash flow from operations is up +63.23% year-on-year

    Cash from investing

    -$853.00M
    LEGN annual cash flow from investing activities is -$853.00 million

    Cash from investing 1-year change

    -1115.77%
    LEGN annual cash flow from investing activities is down -1115.77% year-on-year

    Cash from financing

    $5.70M
    LEGN annual cash flow from financing activities is $5.70 million

    Cash from financing 1-year change

    -99.28%
    LEGN annual cash flow from financing activities is down -99.28% year-on-year

    CAPEX

    CAPEX

    $68.96M
    LEGN annual capital expenditures is $68.96 million

    CAPEX 1-year change

    -43.24%
    LEGN annual capital expenditures is down -43.24% year-on-year

    Free Cash Flow

    Free cash flow

    -$210.31M
    LEGN annual free cash flow is -$210.31 million

    Free cash flow 1-year change

    +58.43%
    LEGN annual free cash flow is up +58.43% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    58.88%
    LEGN annual gross profit margin is 58.88%

    Operating margin

    -49.35%
    LEGN annual operating profit margin is -49.35%

    Net margin

    -28.22%
    LEGN annual net profit margin is -28.22%

    ROA & ROE

    ROA

    -10.06%
    LEGN annual return on assets is -10.06%

    ROE

    -15.45%
    LEGN annual return on equity is -15.45%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LEGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LEGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    6.17
    LEGN price to book ratio is 6.17

    PB ratio Sector rank

    81.73%
    LEGN price to book ratio is higher than 81.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.01
    LEGN price to sales ratio is 8.01

    PS ratio Sector rank

    68.36%
    LEGN price to sales ratio is higher than 68.36% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.81B
    LEGN enterprise value is $5.81 billion

    Enterprise value Sector rank

    88.43%
    LEGN enterprise value is higher than 88.43% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -22.34
    LEGN EV/EBITDA is -22.34

    EV/EBITDA Sector rank

    6.45%
    LEGN EV/EBITDA is higher than 6.45% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.62
    LEGN annual current ratio is 4.62

    Quick ratio

    4.54
    LEGN annual quick ratio is 4.54

    Leverage

    Debt to equity

    0.34
    LEGN annual debt to equity ratio is 0.34

    Interest coverage ratio

    -
    LEGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    LEGN piotroski f-score is 2

    Altman Z-Score

    5.24
    LEGN altman z-score is 5.24

    Analyst ratings

    Recent major analysts updates

    Aug 25, 25 JP Morgan
    Overweight
    Aug 12, 25 RBC Capital
    Outperform
    Aug 12, 25 Morgan Stanley
    Overweight
    Jul 17, 25 HC Wainwright & Co.
    Buy
    Jul 10, 25 Morgan Stanley
    Overweight
    Jul 8, 25 HC Wainwright & Co.
    Buy
    Jul 2, 25 UBS
    Buy
    May 14, 25 Truist Securities
    Buy
    May 14, 25 Cantor Fitzgerald
    Overweight
    Apr 22, 25 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with LEGN included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Legend Biotech Corporation?
    • Does Legend Biotech Corporation pay dividends?
    • What sector is Legend Biotech Corporation in?
    • What industry is Legend Biotech Corporation in?
    • What country is Legend Biotech Corporation based in?
    • When did Legend Biotech Corporation go public?
    • Is Legend Biotech Corporation in the S&P 500?
    • Is Legend Biotech Corporation in the NASDAQ 100?
    • Is Legend Biotech Corporation in the Dow Jones?
    • When was Legend Biotech Corporation's last earnings report?
    • When does Legend Biotech Corporation report earnings?

    What is the ticker symbol for Legend Biotech Corporation?

    The ticker symbol for Legend Biotech Corporation is NASDAQ:LEGN

    Does Legend Biotech Corporation pay dividends?

    No, Legend Biotech Corporation does not pay dividends

    What sector is Legend Biotech Corporation in?

    Legend Biotech Corporation is in the Healthcare sector

    What industry is Legend Biotech Corporation in?

    Legend Biotech Corporation is in the Biotechnology industry

    What country is Legend Biotech Corporation based in?

    Legend Biotech Corporation is headquartered in United States

    When did Legend Biotech Corporation go public?

    Legend Biotech Corporation's initial public offering (IPO) was on June 5, 2020

    Is Legend Biotech Corporation in the S&P 500?

    No, Legend Biotech Corporation is not included in the S&P 500 index

    Is Legend Biotech Corporation in the NASDAQ 100?

    No, Legend Biotech Corporation is not included in the NASDAQ 100 index

    Is Legend Biotech Corporation in the Dow Jones?

    No, Legend Biotech Corporation is not included in the Dow Jones index

    When was Legend Biotech Corporation's last earnings report?

    Legend Biotech Corporation's most recent earnings report was on August 11, 2025

    When does Legend Biotech Corporation report earnings?

    The next expected earnings date for Legend Biotech Corporation is November 11, 2025
    On this page